Ledger.Open graph →
SEC Form D · filed June 13, 2019

Ascus Biosciences, Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Erik Torgerson · San Diego, CADirectorThad Simons · St. Louis, MODirectorMichael Seely · Vista, CAExec · DirectorPeter Innes · Vista, CADirectorJim Kim · Seattle, WADirectorMallory Embree · Vista, CAExec · DirectorEmil Bodenstein · LUTZ, FLDirectorMatthew Luckett · Brooklyn, NYExec · DirectorAndre Hampton · TAMPA, FLExec · DirectorKevin Meredith · TAMPA, FLDirectorBrian Lee · Los Angeles, CADirectorJohn Watson · Evergreen, CODirectorAndrew Benson · Lincoln, NEDirectorTimothy Brummels · Lincoln, NEDirectorXiangyan Sun · Brooklyn, NYExec · DirectorYimin Qian · Brooklyn, NYDirectorQuan Zhou · Brooklyn, NYDirectorKe Liu · Brooklyn, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗